High dose and long-term statin therapy accelerate coronary artery calcification

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 581-586

  Henein, Michael ^a   Granåsen, Gabriel ^a   Wiklund, Urban ^a   Schmermund, Axel ^b   Guerci, Alan ^c   Erbel, Raimund ^d   Raggi, Paolo ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b Bethanien Krankenhaus Frankfurt   (Germany)

^c Heart Center   (United States)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Computed tomography; Coronary artery calcium; Statins

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN; PLACEBO; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; TREATMENT DURATION; CHEMICALLY INDUCED; CONTROLLED STUDY; CORONARY ARTERY DISEASE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME; VASCULAR CALCIFICATION;

AGED; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 84929360502     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.02.072     Document Type: Article

References (35)

1. S. Mohlenkamp, A. Schmermund, N. Lehmann, U. Roggenbuck, N. Dragano, A. Stang, S. Moebus, E.M. Beck, C. Schluter, S. Sack, T. Meinertz, A. Taylor, K.H. Jockel, R. Erbel, Subclinical coronary atherosclerosis and resting ECG abnormalities in an unselected general population, Atherosclerosis 196 (2008) 786-794.
2. M. Charakida, J.E. Deanfield, J.P. Halcox, Childhood origins of arterial disease, Curr. Opin. Pediatr. 19 (2007) 538-545.
3. N. Lehmann, S. Mohlenkamp, A.A. Mahabadi, A. Schmermund, U. Roggenbuck, R. Seibel, D. Gronemeyer, T. Budde, N. Dragano, A. Stang, K. Mann, S. Moebus, R. Erbel, K.H. Jockel, Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study, Atherosclerosis 232 (2014) 339-345.
4. Y. Arad, L.A. Spadaro, M. Roth, D. Newstein, A.D. Guerci, Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial, J. Am. Coll. Cardiol. 46 (2005) 166-172.
5. E.S. Houslay, S.J. Cowell, R.J. Prescott, J. Reid, J. Burton, D.B. Northridge, N.A. Boon, D.E. Newby, Progressive coronary calcification despite intensive lipid-lowering treatment: A randomised controlled trial, Heart 92 (2006) 1207-1212.
6. P. Raggi, M. Davidson, T.Q. Callister, F.K. Welty, G.A. Bachmann, H. Hecht, J.A. Rumberger, Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES), Circulation 112 (2005) 563-571.
7. A. Schmermund, S. Achenbach, T. Budde, Y. Buziashvili, A. Forster, G. Friedrich, M. Henein, G. Kerkhoff, F. Knollmann, V. Kukharchuk, A. Lahiri, R. Leischik, W. Moshage, M. Schartl, W. Siffert, E. Steinhagen-Thiessen, V. Sinitsyn, A. Vogt, B. Wiedeking, R. Erbel, Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12months: Amulticenter, randomized, double-blind trial, Circulation 113 (2006) 427-437.
8. J.G. Terry, J.J. Carr, E.O. Kouba, D.H. Davis, L. Menon, K. Bender, E.T. Chandler, T. Morgan, J.R. Crouse III, Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the Coronary Artery calcification Treatment with Zocor [CATZ] study), Am. J. Cardiol. 99 (2007) 1714-1717.
9. M.Y. Henein, A. Owen, Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses, Int. J. Cardiol. 153 (2011) 31-35.
10. J.A. Beckman, J. Ganz, M.A. Creager, P. Ganz, S. Kinlay, Relationship of clinical presentation and calcification of culprit coronary artery stenoses, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1618-1622.
11. X.Q. Zhao, C. Yuan, T.S. Hatsukami, E.H. Frechette, X.J. Kang, K.R. Maravilla, B.G. Brown, Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1623-1629.
12. Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci, Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study, J. Am. Coll. Cardiol. 46 (2005) 158-165.
13. M.J. Budoff, J.E.Hokanson, K.Nasir, L.J. Shaw, G.L. Kinney, D. Chow, D.Demoss, V. Nuguri, V. Nabavi, R. Ratakonda, D.S. Berman, P. Raggi, Progression of coronary artery calcium predicts all-cause mortality, JACC Cardiovasc. Imaging 3 (2010) 1229-1236.
14. M.J. Budoff, R. Young, V.A. Lopez, R.A. Kronmal, K. Nasir, R.S. Blumenthal, R.C. Detrano, D.E. Bild, A.D. Guerci, K. Liu, S. Shea, M. Szklo, W. Post, J. Lima, A. Bertoni, N.D. Wong, Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis), J. Am. Coll. Cardiol. 61 (2013) 1231-1239.
15. S. Kiramijyan, N. Ahmadi, H. Isma'eel, F. Flores, L.J. Shaw, P. Raggi, M.J. Budoff, Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus, Am. J. Cardiol. 111 (2013) 356-361.
16. P. Raggi, T.Q. Callister, L.J. Shaw, Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy, Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1272-1277.
17. P. Raggi, B. Cooil, C. Ratti, T.Q. Callister, M. Budoff, Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus, Hypertension 46 (2005) 238-243.
18. P. Raggi, B. Cooil, L.J. Shaw, J. Aboulhson, J. Takasu, M. Budoff, T.Q. Callister, Progression of coronary calcium on serial electron beamtomographic scanning is greater in patients with future myocardial infarction, Am. J. Cardiol. 92 (2003) 827-829.
19. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., R. Detrano, Quantification of coronary artery calcium using ultrafast computed tomography, J. Am. Coll. Cardiol. 15 (1990) 827-832.
20. V. Fuster, B. Stein, J.A. Ambrose, L. Badimon, J.J. Badimon, J.H. Chesebro, Atherosclerotic plaque rupture and thrombosis. Evolving concepts, Circulation 82 (1990) 47-59.
21. S.E. New, E. Aikawa, Role of extracellular vesicles in de novo mineralization: An additional novel mechanism of cardiovascular calcification, Arterioscler. Thromb. Vasc. Biol. 33 (2013) 1753-1758.
22. A. Holmgren, G. Rumsby, S. Gustafsson, U. Naslund, M.Y. Henein, The nature of cardiac calcification in aortic stenosis, Int. J. Cardiol. 158 (2012) 319-321.
23. B.A. Arnold, P. Xiang, M.J. Budoff, S.S. Mao, Very small calcifications are detected and scored in the coronary arteries from small voxel MDCT images using a new automated/calibrated scoring method with statistical and patient specific plaque definitions, Int. J. Cardiovasc. Imaging 28 (2012) 1193-1204.
24. M.G. Silverman, M.J. Blaha, H.M. Krumholz, M.J. Budoff, R. Blankstein, C.T. Sibley, A. Agatston, R.S. Blumenthal, K. Nasir, Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: The Multi-Ethnic Study of Atherosclerosis, Eur. Heart J. 35 (33) (2014) 2232-2241.
25. R. Erbel, M. Budoff, Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: The memory of lifetime risk factor exposure, Eur. Heart J. 33 (2012) 1201-1213.
26. S. Achenbach, D. Ropers, K. Pohle, A. Leber, C. Thilo, A. Knez, T. Menendez, R. Maeffert, M. Kusus, M. Regenfus, A. Bickel, R. Haberl, G. Steinbeck, W. Moshage, W.G. Daniel, Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation, Circulation 106 (2002) 1077-1082.
27. T.Q. Callister, P. Raggi, B. Cooil, N.J. Lippolis, D.J. Russo, Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography, N. Engl. J. Med. 339 (1998) 1972-1978.
28. R. Puri, P. Libby, S.E. Nissen, K.Wolski, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R. Erbel, J.S. Raichlen, K. Uno, Y. Kataoka, E.M. Tuzcu, S.J. Nicholls, Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: Insights from SATURN, Eur. Heart J. Cardiovasc. Imaging 15 (4) (2014) 380-388.
29. P. Eshtehardi, M.C. McDaniel, S.S. Dhawan, J.N. Binongo, S.K. Krishnan, L. Golub, M.T. Corban, P. Raggi, A.A. Quyyumi, H. Samady, Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function, J. Invasive Cardiol. 24 (10) (2012) 522-529.
30. T.S. Ferreira, M. Lanzetti, M.V. Barroso, C.R. Rueff-Barroso, C.F. Benjamim, L. de Brito- Gitirana, L.C. Porto, S.S. Valenca, Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke, Inflammation 37 (5) (2014) 1355-1365.
31. T. Takayama, T. Hiro, Y. Ueda, J. Honye, S. Komatsu, O. Yamaguchi, Y. Li, J. Yajima, K. Takazawa, S. Nanto, S. Saito, A. Hirayama, K. Kodama, Plaque stabilization by intensive LDL-cholesterol lowering therapywith atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-serial angioscopic and intravascular ultrasound analysis, J. Cardiol. 61 (2013) 381-386.
32. B.Wu, S. Elmariah, F.S. Kaplan, G. Cheng, E.R.Mohler III, Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: Implications for end-stage valvular heart disease, Arterioscler. Thromb. Vasc. Biol. 25 (2005) 592-597.
33. M.J. Budoff, S. Achenbach, R.S. Blumenthal, J.J. Carr, J.G. Goldin, P. Greenland, A.D. Guerci, J.A. Lima, D.J. Rader, G.D. Rubin, L.J. Shaw, S.E. Wiegers, American Heart Association Committee on Cardiovascular I, Intervention, American Heart Association Council on Cardiovascular R, Intervention, American Heart Association Committee on Cardiac Imaging CoCC. Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology, Circulation 114 (2006) 1761-1791.
34. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, S. Coady, R.B. D'Agostino Sr., R. Gibbons, P. Greenland, D.T. Lackland, D. Levy, C.J. O'Donnell, J.G. Robinson, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., P. Sorlie, N.J. Stone, P.W. Wilson, American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 63 (2014) 2935-2959.
35. P. Greenland, J.S. Alpert, G.A. Beller, E.J. Benjamin, M.J. Budoff, Z.A. Fayad, E. Foster, M.A. Hlatky, J.M. Hodgson, F.G. Kushner, M.S. Lauer, L.J. Shaw, S.C. Smith Jr., A.J. Taylor, W.S. Weintraub, N.K. Wenger, A.K. Jacobs, S.C. Smith Jr., J.L. Anderson, N. Albert, C.E. Buller, M.A. Creager, S.M. Ettinger, R.A. Guyton, J.L. Halperin, J.S. Hochman, F.G. Kushner, R. Nishimura, E.M. Ohman, R.L. Page, W.G. Stevenson, L.G. Tarkington, C.W. Yancy, American College of Cardiology F, American Heart A. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 56 (2010) e50-e103.